Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 328

1.

Development and external validation of a dynamic prognostic nomogram for primary extremity soft tissue sarcoma survivors.

Callegaro D, Miceli R, Bonvalot S, Ferguson PC, Strauss DC, van Praag VVM, Levy A, Griffin AM, Hayes AJ, Stacchiotti S, Pèchoux CL, Smith MJ, Fiore M, Tos APD, Smith HG, Catton C, Szkandera J, Leithner A, van de Sande MAJ, Casali PG, Wunder JS, Gronchi A.

EClinicalMedicine. 2019 Nov 22;17:100215. doi: 10.1016/j.eclinm.2019.11.008. eCollection 2019 Dec.

2.

Prognostic and Predictive Value of Microsatellite Instability, Inflammatory Reaction and PD-L1 in Gastric Cancer Patients Treated with Either Adjuvant 5-FU/LV or Sequential FOLFIRI Followed by Cisplatin and Docetaxel: A Translational Analysis from the ITACA-S Trial.

Di Bartolomeo M, Morano F, Raimondi A, Miceli R, Corallo S, Tamborini E, Perrone F, Antista M, Niger M, Pellegrinelli A, Randon G, Pagani F, Martinetti A, Fucà G, Pietrantonio F; ITACA‐S study group.

Oncologist. 2019 Nov 25. pii: theoncologist.2019-0471. doi: 10.1634/theoncologist.2019-0471. [Epub ahead of print]

3.

No indication for right heart catheterisation for patients with isolated severe obstructive sleep apnoea syndrome according to a guideline-recommended approach.

Miceli R, Colombo D, Scagliola R, Balbi M, Braido F, Ameri P.

Eur J Prev Cardiol. 2019 Oct 4:2047487319878106. doi: 10.1177/2047487319878106. [Epub ahead of print] No abstract available.

PMID:
31581821
4.

Sorafenib Versus Observation Following Radical Metastasectomy for Clear-cell Renal Cell Carcinoma: Results from the Phase 2 Randomized Open-label RESORT Study.

Procopio G, Apollonio G, Cognetti F, Miceli R, Milella M, Mosca A, Chiuri VE, Bearz A, Morelli F, Ortega C, Atzori F, Donini M, Ratta R, Raimondi A, Claps M, Martinetti A, Capitanio U, de Braud FG, Cappelletti V, Verzoni E.

Eur Urol Oncol. 2019 Nov;2(6):699-707. doi: 10.1016/j.euo.2019.08.011. Epub 2019 Sep 19.

PMID:
31542243
5.

Safety and tolerability of ubrogepant following intermittent, high-frequency dosing: Randomized, placebo-controlled trial in healthy adults.

Goadsby PJ, Tepper SJ, Watkins PB, Ayele G, Miceli R, Butler M, Severt L, Finnegan M, Szegedi A, Trugman JM, Jakate A.

Cephalalgia. 2019 Dec;39(14):1753-1761. doi: 10.1177/0333102419869918. Epub 2019 Sep 19.

6.

Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer.

Pietrantonio F, Miceli R, Raimondi A, Kim YW, Kang WK, Langley RE, Choi YY, Kim KM, Nankivell MG, Morano F, Wotherspoon A, Valeri N, Kook MC, An JY, Grabsch HI, Fucà G, Noh SH, Sohn TS, Kim S, Di Bartolomeo M, Cunningham D, Lee J, Cheong JH, Smyth EC.

J Clin Oncol. 2019 Dec 10;37(35):3392-3400. doi: 10.1200/JCO.19.01124. Epub 2019 Sep 12.

PMID:
31513484
7.

Clinical Characteristics and Long-Term Mortality Rate in Female Patients with Takotsubo Syndrome Compared with Female Patients with ST-Elevation Acute Myocardial Infarction: A Retrospective Study from a Single Center.

Massobrio L, Valbusa A, Sartini M, Meliota G, Cavalla F, Miceli R, Vischi G, Cristina ML, Spagnolo AM, Delfino R, Abbadessa F, Porto I, Brunelli C, Rosa GM.

Cardiol Res Pract. 2019 Jul 30;2019:9156586. doi: 10.1155/2019/9156586. eCollection 2019.

8.

Prognostic role of primary tumor, nodal neck, and retropharyngeal GTVs for unresectable sinonasal cancers treated with IMRT and chemotherapy.

Ferella L, Cavallo A, Miceli R, Iacovelli NA, Giandini T, Pignoli E, Calareso G, Bossi P, Resteghini C, Gravina GL, Nicolai P, Castelnuovo P, Piazza C, Licitra L, Fallai C, Orlandi E.

Tumori. 2020 Feb;106(1):39-46. doi: 10.1177/0300891619868006. Epub 2019 Aug 27.

PMID:
31451102
9.

Locally advanced epithelial sinonasal tumors: The impact of multimodal approach.

Orlandi E, Cavalieri S, Granata R, Nicolai P, Castelnuovo P, Piazza C, Schreiber A, Turri-Zanoni M, Quattrone P, Miceli R, Infante G, Sessa F, Facco C, Calareso G, Iacovelli NA, Mattavelli D, Paderno A, Resteghini C, Locati LD, Licitra L, Bossi P.

Laryngoscope. 2019 Aug 1. doi: 10.1002/lary.28202. [Epub ahead of print]

PMID:
31369156
10.

Long-term outcome of re-irradiation for recurrent or second primary head and neck cancer: A multi-institutional study of AIRO-Head and Neck working group.

Orlandi E, Bonomo P, Ferella L, D'Angelo E, Maddalo M, Alterio D, Infante G, Bacigalupo A, Argenone A, Iacovelli NA, Desideri I, Meduri B, Triggiani L, Volpe S, Belgioia L, Dionisi F, Romanello DA, Fallai C, Miceli R.

Head Neck. 2019 Oct;41(10):3684-3692. doi: 10.1002/hed.25890. Epub 2019 Jul 29.

PMID:
31355972
11.

Conditioned medium of primary lung cancer cells induces EMT in A549 lung cancer cell line by TGF-ß1 and miRNA21 cooperation.

Camerlingo R, Miceli R, Marra L, Rea G, D'Agnano I, Nardella M, Montella R, Morabito A, Normanno N, Tirino V, Rocco G.

PLoS One. 2019 Jul 25;14(7):e0219597. doi: 10.1371/journal.pone.0219597. eCollection 2019.

12.

Intraperitoneal Invasion of Retroperitoneal Sarcomas: A Risk Factor for Dismal Prognosis.

Nizri E, Fiore M, Barretta F, Colombo C, Radaelli S, Callegaro D, Sanfilippo R, Sangalli C, Collini P, Stacchiotti S, Casali PG, Miceli R, Gronchi A.

Ann Surg Oncol. 2019 Oct;26(11):3535-3541. doi: 10.1245/s10434-019-07615-1. Epub 2019 Jul 16.

PMID:
31313035
13.

Maintenance Therapy With Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients With RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial.

Pietrantonio F, Morano F, Corallo S, Miceli R, Lonardi S, Raimondi A, Cremolini C, Rimassa L, Bergamo F, Sartore-Bianchi A, Tampellini M, Racca P, Clavarezza M, Berenato R, Caporale M, Antista M, Niger M, Smiroldo V, Murialdo R, Zaniboni A, Adamo V, Tomasello G, Giordano M, Petrelli F, Longarini R, Cinieri S, Falcone A, Zagonel V, Di Bartolomeo M, de Braud F.

JAMA Oncol. 2019 Jul 3. doi: 10.1001/jamaoncol.2019.1467. [Epub ahead of print]

14.

Microenvironment and tumor inflammatory features improve prognostic prediction in gastro-entero-pancreatic neuroendocrine neoplasms.

Milione M, Miceli R, Barretta F, Pellegrinelli A, Spaggiari P, Tagliabue G, Centonze G, Paolino C, Mangogna A, Kankava K, Pusceddu S, Giacomelli L, Corti A, Cotsoglou C, Mazzaferro V, Sozzi G, de Braud F, Pruneri G, Anichini A.

J Pathol Clin Res. 2019 Oct;5(4):217-226. doi: 10.1002/cjp2.135. Epub 2019 Jul 9.

15.

Prognostic Impact of Microsatellite Instability in Asian Gastric Cancer Patients Enrolled in the ARTIST Trial.

Miceli R, An J, Di Bartolomeo M, Morano F, Kim ST, Park SH, Choi MG, Lee JH, Raimondi A, Fucà G, Sohn TS, Bae JM, Kim S, Lim DH, Kang WK, Kim KM, Pietrantonio F, Lee J.

Oncology. 2019;97(1):38-43. doi: 10.1159/000499628. Epub 2019 May 2.

PMID:
31048579
16.

Interfraction prostate displacement during image-guided radiotherapy using intraprostatic fiducial markers and a cone-beam computed tomography system: A volumetric off-line analysis in relation to the variations of rectal and bladder volumes.

Ingrosso G, Miceli R, Ponti E, Lancia A, di Cristino D, de Pasquale F, Bove P, Santoni R.

J Cancer Res Ther. 2019 Mar;15(Supplement):S69-S75. doi: 10.4103/jcrt.JCRT_463_17.

17.

Sacubitril/valsartan improves both functional and echocardiographic parameters in patients with chronic heart failure with reduced ejection fraction.

Cosentino ER, Degli Esposti D, Miceli R, Bentivenga C, Landolfo M, Fg Cicero A, Berardi E, Spinardi L, Magri G, Dugato V, Borghi C.

Curr Med Res Opin. 2019 Mar;35(sup1):9-12. doi: 10.1080/03007995.2019.1576481.

PMID:
30864900
18.

Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure.

Bertero E, Miceli R, Lorenzoni A, Balbi M, Ghigliotti G, Chiarella F, Brunelli C, Viazzi F, Pontremoli R, Canepa M, Ameri P.

Intern Emerg Med. 2019 Oct;14(7):1083-1090. doi: 10.1007/s11739-019-02060-0. Epub 2019 Mar 5.

PMID:
30835055
19.

Outcome of iliocaval resection and reconstruction for retroperitoneal sarcoma.

Ferraris M, Callegaro D, Barretta F, Fiore M, Radaelli S, Stacchiotti S, Miceli R, Socrate AM, Locati P, Gronchi A.

J Vasc Surg Venous Lymphat Disord. 2019 Jul;7(4):547-556. doi: 10.1016/j.jvsv.2018.10.023. Epub 2019 Feb 18.

PMID:
30792153
20.

The impact of ionizing irradiation on liver detoxifying enzymes. A re-investigation.

Bocedi A, Ingrosso G, Cattani G, Miceli R, Ponti E, Lancia A, Baldelli S, Guidi A, Ciriolo MR, Mattei M, Ricci G.

Cell Death Discov. 2019 Feb 8;5:66. doi: 10.1038/s41420-019-0148-8. eCollection 2019.

21.

Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG.

Raut CP, Callegaro D, Miceli R, Barretta F, Rutkowski P, Blay JY, Lahat G, Strauss DC, Gonzalez R, Ahuja N, Grignani G, Quagliuolo V, Stoeckle E, De Paoli A, Pillarisetty VG, Nessim C, Swallow CJ, Bagaria S, Canter R, Mullen J, Gelderblom HJ, Pennacchioli E, van Coevorden F, Cardona K, Fiore M, Fairweather M, Gronchi A.

Clin Cancer Res. 2019 Apr 15;25(8):2664-2671. doi: 10.1158/1078-0432.CCR-18-2700. Epub 2019 Feb 5.

PMID:
30723141
22.

Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients?

Nichetti F, Falvella FS, Miceli R, Cheli S, Gaetano R, Fucà G, Infante G, Martinetti A, Antoniotti C, Falcone A, Di Bartolomeo M, Cremolini C, de Braud F, Pietrantonio F.

Pharmacogenomics J. 2019 Oct;19(5):465-472. doi: 10.1038/s41397-019-0078-0. Epub 2019 Feb 4.

PMID:
30713338
23.

Prevalence of Fatigue in Head and Neck Cancer Survivors.

Bossi P, Di Pede P, Guglielmo M, Granata R, Alfieri S, Iacovelli NA, Orlandi E, Guzzo M, Bianchi R, Ferella L, Infante G, Miceli R, Licitra L, Ripamonti CI.

Ann Otol Rhinol Laryngol. 2019 May;128(5):413-419. doi: 10.1177/0003489419826138. Epub 2019 Jan 30.

PMID:
30700107
24.

Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck.

Mirabile A, Miceli R, Calderone RG, Locati L, Bossi P, Bergamini C, Granata R, Perrone F, Mariani L, Licitra L.

Head Neck. 2019 Jun;41(6):1895-1902. doi: 10.1002/hed.25636. Epub 2019 Jan 16.

PMID:
30652392
25.

Morbidity and mortality in a population of patients affected by heart failure and chronic obstructive pulmonary disease: an observational study.

Cosentino ER, Landolfo M, Bentivenga C, Spinardi L, Esposti DD, Cicero AF, Miceli R, Bui V, Berardi E, Borghi C.

BMC Cardiovasc Disord. 2019 Jan 16;19(1):20. doi: 10.1186/s12872-018-0986-y.

26.

Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety.

Rappo U, Puttagunta S, Shevchenko V, Shevchenko A, Jandourek A, Gonzalez PL, Suen A, Mas Casullo V, Melnick D, Miceli R, Kovacevic M, De Bock G, Dunne MW.

Open Forum Infect Dis. 2018 Dec 10;6(1):ofy331. doi: 10.1093/ofid/ofy331. eCollection 2019 Jan.

27.

Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma.

Dodero A, Guidetti A, Tucci A, Barretta F, Novo M, Devizzi L, Re A, Passi A, Pellegrinelli A, Pruneri G, Miceli R, Testi A, Pennisi M, Di Chio MC, Matteucci P, Carniti C, Facchetti F, Rossi G, Corradini P.

Leukemia. 2019 Apr;33(4):1047-1051. doi: 10.1038/s41375-018-0320-9. Epub 2019 Jan 10. No abstract available.

28.

Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working Group.

Haas RLM, Bonvalot S, Miceli R, Strauss DC, Swallow CJ, Hohenberger P, van Coevorden F, Rutkowski P, Callegaro D, Hayes AJ, Honoré C, Fairweather M, Gladdy R, Jakob J, Szacht M, Fiore M, Chung PW, van Houdt WJ, Raut CP, Gronchi A.

Cancer. 2019 Apr 15;125(8):1290-1300. doi: 10.1002/cncr.31927. Epub 2019 Jan 2.

29.

Impact of treatment expertise on the outcome of patients with head and neck cancer treated within 6 randomized trials.

Bossi P, Miceli R, Benasso M, Corvò R, Bacigalupo A, Sanguineti G, Fallai C, Merlano MC, Infante G, Dani C, Di Giannantonio V, Licitra L.

Head Neck. 2018 Dec;40(12):2648-2656. doi: 10.1002/hed.25389. Epub 2018 Nov 17.

PMID:
30447127
30.

Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres.

Callegaro D, Miceli R, Bonvalot S, Ferguson P, Strauss DC, Levy A, Griffin A, Hayes AJ, Stacchiotti S, Le Pèchoux C, Smith MJ, Fiore M, Dei Tos AP, Smith HG, Catton C, Casali PG, Wunder JS, Gronchi A.

Eur J Cancer. 2018 Dec;105:19-27. doi: 10.1016/j.ejca.2018.09.028. Epub 2018 Oct 29.

PMID:
30384013
31.

In Reply to Fakhry et al.

Bossi P, Miceli R, Granata R, Naimo S, Infante G, Locati LD, Iacovelli NA, Fallai C, Orlandi E, Licitra L.

Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):670-671. doi: 10.1016/j.ijrobp.2018.06.019. No abstract available.

PMID:
30238903
32.

Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancer.

Andriani F, Landoni E, Mensah M, Facchinetti F, Miceli R, Tagliabue E, Giussani M, Callari M, De Cecco L, Colombo MP, Roz L, Pastorino U, Sozzi G.

BMC Cancer. 2018 Sep 18;18(1):899. doi: 10.1186/s12885-018-4772-0.

33.

Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram.

Pietrantonio F, Barretta F, Fanotto V, Park SH, Morano F, Fucà G, Niger M, Prisciandaro M, Silvestris N, Bergamo F, Fornaro L, Bordonaro R, Rimassa L, Santini D, Tomasello G, Antonuzzo L, Noventa S, Avallone A, Leone F, Faloppi L, Di Donato S, de Braud F, Lee J, De Vita F, Di Bartolomeo M, Miceli R, Aprile G.

Oncology. 2018;95(6):344-352. doi: 10.1159/000491753. Epub 2018 Aug 21.

PMID:
30130791
34.

Predictors of Patient-Reported Dysphagia Following IMRT Plus Chemotherapy in Oropharyngeal Cancer.

Orlandi E, Miceli R, Infante G, Mirabile A, Alterio D, Cossu Rocca M, Denaro N, Vigna-Taglianti R, Merlotti A, Schindler A, Pizzorni N, Fallai C, Licitra L, Bossi P.

Dysphagia. 2019 Feb;34(1):52-62. doi: 10.1007/s00455-018-9913-8. Epub 2018 Jun 8.

35.

Correction to: Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood.

Massimino M, Biassoni V, Miceli R, Schiavello E, Warmuth-Metz M, Modena P, Casanova M, Pecori E, Giangaspero F, Antonelli M, Buttarelli FR, Potepan P, Pollo B, Nunziata R, Spreafico F, Podda M, Anichini A, Clerici CA, Sardi I, De Cecco L, Bode U, Bach F, Gandola L.

J Neurooncol. 2018 Jul;138(3):679-680. doi: 10.1007/s11060-018-2893-6.

PMID:
29767306
36.

Trifluridine/Tipiracil (TAS-102) in Refractory Metastatic Colorectal Cancer: A Multicenter Register in the Frame of the Italian Compassionate Use Program.

Cremolini C, Rossini D, Martinelli E, Pietrantonio F, Lonardi S, Noventa S, Tamburini E, Frassineti GL, Mosconi S, Nichetti F, Murgioni S, Troiani T, Borelli B, Zucchelli G, Dal Maso A, Sforza V, Masi G, Antoniotti C, Di Bartolomeo M, Miceli R, Ciardiello F, Falcone A.

Oncologist. 2018 Oct;23(10):1178-1187. doi: 10.1634/theoncologist.2017-0573. Epub 2018 May 8.

37.

Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer.

Cavalieri S, Perrone F, Miceli R, Ascierto PA, Locati LD, Bergamini C, Granata R, Alfieri S, Resteghini C, Galbiati D, Busico A, Paielli N, Patuzzo R, Maurichi A, Gallino G, Ruggeri R, Mariani L, Palla M, Licitra L, Bossi P.

Eur J Cancer. 2018 Jul;97:7-15. doi: 10.1016/j.ejca.2018.04.004. Epub 2018 May 4.

PMID:
29734047
38.

Prognostic role of PIK3CA and TP53 in human papillomavirus-negative oropharyngeal cancers.

Resteghini C, Perrone F, Miceli R, Bergamini C, Alfieri S, Orlandi E, Guzzo M, Granata R, Galbiati D, Cavalieri S, Locati L, Licitra L, Bossi P.

Tumori. 2018 Jun;104(3):213-220. doi: 10.1177/0300891618765558. Epub 2018 Apr 18.

PMID:
29714670
39.

Coexisting Heart Failure and Chronic Obstructive Pulmonary Disease: Report of Two Cases Treated with Indacaterol/Glycopyrronium.

Cosentino ER, Degli Esposti D, Miceli R, Bentivenga C, Landolfo M, Ricci Iamino I, Spinardi L, Magri G, Borghi C.

Respiration. 2018;95 Suppl 1:3-5. doi: 10.1159/000487169. Epub 2018 Apr 27.

40.

Urn models for response-adaptive randomized designs: a simulation study based on a non-adaptive randomized trial.

Ghiglietti A, Scarale MG, Miceli R, Ieva F, Mariani L, Gavazzi C, Paganoni AM, Edefonti V.

J Biopharm Stat. 2018;28(6):1203-1215. doi: 10.1080/10543406.2018.1452024. Epub 2018 Mar 22.

41.

A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors.

Pusceddu S, Barretta F, Trama A, Botta L, Milione M, Buzzoni R, De Braud F, Mazzaferro V, Pastorino U, Seregni E, Mariani L, Gatta G, Di Bartolomeo M, Femia D, Prinzi N, Coppa J, Panzuto F, Antonuzzo L, Bajetta E, Brizzi MP, Campana D, Catena L, Comber H, Dwane F, Fazio N, Faggiano A, Giuffrida D, Henau K, Ibrahim T, Marconcini R, Massironi S, Žakelj MP, Spada F, Tafuto S, Van Eycken E, Van der Zwan JM, Žagar T, Giacomelli L, Miceli R; NEPscore Working Group.

Endocr Relat Cancer. 2018 Jun;25(6):607-618. doi: 10.1530/ERC-17-0489. Epub 2018 Mar 20.

42.

MiR-16 regulates the pro-tumorigenic potential of lung fibroblasts through the inhibition of HGF production in an FGFR-1- and MEK1-dependent manner.

Andriani F, Majorini MT, Mano M, Landoni E, Miceli R, Facchinetti F, Mensah M, Fontanella E, Dugo M, Giacca M, Pastorino U, Sozzi G, Delia D, Roz L, Lecis D.

J Hematol Oncol. 2018 Mar 20;11(1):45. doi: 10.1186/s13045-018-0594-4.

43.

Extracellular matrix proteins as diagnostic markers of breast carcinoma.

Giussani M, Landoni E, Merlino G, Turdo F, Veneroni S, Paolini B, Cappelletti V, Miceli R, Orlandi R, Triulzi T, Tagliabue E.

J Cell Physiol. 2018 Aug;233(8):6280-6290. doi: 10.1002/jcp.26513. Epub 2018 Mar 9.

PMID:
29521413
44.

Failure of Further Validation for Survival Nomograms in Oropharyngeal Cancer: Issues and Challenges.

Bossi P, Miceli R, Granata R, Naimo S, Infante G, Locati LD, Iacovelli NA, Fallai C, Licitra L, Orlandi E.

Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1217-1221. doi: 10.1016/j.ijrobp.2017.12.281. Epub 2017 Dec 28.

PMID:
29395630
45.

Antioxidant and anti-proliferative properties of extracts from heterotrophic cultures of Galdieria sulphuraria.

Bottone C, Camerlingo R, Miceli R, Salbitani G, Sessa G, Pirozzi G, Carfagna S.

Nat Prod Res. 2019 Jun;33(11):1659-1663. doi: 10.1080/14786419.2018.1425853. Epub 2018 Jan 15.

PMID:
29334254
46.

Do Knee Bracing and Delayed Weight Bearing Affect Mid-Term Functional Outcome after Anterior Cruciate Ligament Reconstruction?

Di Miceli R, Marambio CB, Zati A, Monesi R, Benedetti MG.

Joints. 2017 Sep 15;5(4):202-206. doi: 10.1055/s-0037-1606617. eCollection 2017 Dec.

47.

Performance of commercially available deformable image registration platforms for contour propagation using patient-based computational phantoms: A multi-institutional study.

Loi G, Fusella M, Lanzi E, Cagni E, Garibaldi C, Iacoviello G, Lucio F, Menghi E, Miceli R, Orlandini LC, Roggio A, Rosica F, Stasi M, Strigari L, Strolin S, Fiandra C.

Med Phys. 2018 Feb;45(2):748-757. doi: 10.1002/mp.12737. Epub 2018 Jan 9.

PMID:
29266262
48.

Prognostic models for RPS patients-Attempting to predict patient outcomes.

Callegaro D, Miceli R, Gladdy RA.

J Surg Oncol. 2018 Jan;117(1):69-78. doi: 10.1002/jso.24903. Epub 2017 Dec 19. Review.

PMID:
29266220
49.

Post-surgery fluids promote transition of cancer stem cell-to-endothelial and AKT/mTOR activity, contributing to relapse of giant cell tumors of bone.

Fazioli F, Colella G, Miceli R, Di Salvatore MG, Gallo M, Boccella S, De Chiara A, Ruosi C, de Nigris F.

Oncotarget. 2017 Jun 28;8(49):85040-85053. doi: 10.18632/oncotarget.18783. eCollection 2017 Oct 17.

50.

Early reduction of serum TARC levels may predict for success of ABVD as frontline treatment in patients with Hodgkin Lymphoma.

Guidetti A, Mazzocchi A, Miceli R, Paterno' E, Taverna F, Spina F, Crippa F, Farina L, Corradini P, Gianni AM, Viviani S.

Leuk Res. 2017 Nov;62:91-97. doi: 10.1016/j.leukres.2017.09.018. Epub 2017 Sep 25.

PMID:
28992524

Supplemental Content

Loading ...
Support Center